Common Contracts
4 similar Services Agreement contracts by Axovant Sciences Ltd., Myovant Sciences Ltd.
AMENDED AND RESTATED SERVICES AGREEMENTServices Agreement • February 14th, 2017 • Axovant Sciences Ltd. • Pharmaceutical preparations • New York
This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of December 13, 2016 (the “Effective Date”), by and among Roivant Sciences, Inc., a corporation organized under the laws of the State of Delaware (“Service Provider”), Axovant Sciences GmbH, a company with limited liability organized under the laws of the country of Switzerland (“ASG”), Axovant Sciences, Inc. (f/k/a Roivant Neurosciences, Inc.), a corporation organized under the laws of the State of Delaware (“ASI”), and Axovant Sciences Ltd. (f/k/a Roivant Neurosciences Ltd.), an exempted limited company organized under the laws of the country of Bermuda (“ASL”, and together with ASI and ASG, the “Service Recipients” and each a “Service Recipient”).
AMENDED AND RESTATED SERVICES AGREEMENTServices Agreement • February 13th, 2017 • Myovant Sciences Ltd. • Pharmaceutical preparations • New York
This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of November 11, 2016 (the “Effective Date”), by and among Roivant Sciences, Inc., a corporation organized under the laws of the State of Delaware (“Service Provider”), Myovant Sciences GmbH, a company with limited liability organized under the laws of the country of Switzerland (“MSG”), Myovant Sciences, Inc. (f/k/a Roivant Endocrinology, Inc.), a corporation organized under the laws of the State of Delaware (“MSI”), and Myovant Sciences Ltd. (f/k/a Roivant Endocrinology Ltd.), an exempted limited company organized under the laws of the country of Bermuda (“MSL”, and together with MSI and MSG, the “Service Recipients” and each a “Service Recipient”).
SERVICES AGREEMENTServices Agreement • September 30th, 2016 • Myovant Sciences Ltd. • Pharmaceutical preparations • New York
This Services Agreement (the “Agreement”) is entered into effective as of April 29, 2016 (the “Effective Date”), by and between Roivant Sciences, Inc., a corporation organized under the laws of the State of Delaware (“Service Provider”), Myovant Sciences Ltd., an exempted limited company organized under the laws of the country of Bermuda (“MSL”), and Myovant Sciences, Inc., a corporation organized under the laws of the State of Delaware and a wholly owned subsidiary of MSL (“MSI”, and together with MSL, the “Service Recipients” and each a “Service Recipient”).
AMENDED AND RESTATED SERVICES AGREEMENTServices Agreement • February 9th, 2016 • Axovant Sciences Ltd. • Pharmaceutical preparations • New York
This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of October 13, 2015 (the “Effective Date”), by and between Roivant Sciences, Inc., a corporation organized under the laws of the State of Delaware (“Service Provider”), Axovant Sciences Ltd. (f/k/a Roivant Neurosciences Ltd.), an exempted limited company organized under the laws of the country of Bermuda (“RNL”), and Axovant Sciences, Inc. (f/k/a Roivant Neurosciences, Inc.), a corporation organized under the laws of the State of Delaware and a wholly owned subsidiary of RNL (“RNI”, and together with RNL, the “Service Recipients” and each a “Service Recipient”).
